Hear from these and other distinguished leaders at the Combination Products Regulatory & Compliance Summit on September 23-24 in Baltimore to answer your most pressing issues in the industry.
Speaking Faculty includes:
Angela C. Krueger, Regulatory Advisor, CDRH Product Jurisdictional Officer, Office of Device Evaluation, FDA
Understand and Anticipate Combination Product Activity at the FDA
John Kinzell, President & CEO, XERIS PHARMACEUTICALS
Understand and Anticipate Combination Product Activity at the FDA
Eric Edwards, Co-Founder & Chief Scientist, INTELLIJECT
Interpret Auto-Injector Guidance Ambiguities to Compliantly Adapt Best Practices
Michael Gross, Senior Consultant, BIOLOGIC CONSULTING GROUP
Minimize Enforcement Risk Through cGMP Compliance
Asif Sidiqui, Director, Regulatory Affairs, ROCHE MOLECULAR SYSTEMS
Learn What the FDA Looks for in Combination Product Clinical Trials to Avoid Early Life-Cycle Missteps
Suzanne Kiani, Senior Scientist, CMC Regulatory Affairs, GENENTECH
Minimize Enforcement Risk Through cGMP Compliance
View the complete agenda for all speakers and presentations here:
http://bit.ly/cqxdcP
Visit the webpage here:
http://bit.ly/d3J6Hk
|
Share this article with your social network, just click below to share now!
|
|
|
